PeptiDream Inc
TSE:4587
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 168.5
2 968
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
PeptiDream Inc
Total Other Income
PeptiDream Inc
Total Other Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
PeptiDream Inc
TSE:4587
|
Total Other Income
-ÂĄ1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
GNI Group Ltd
TSE:2160
|
Total Other Income
ÂĄ0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Takara Bio Inc
TSE:4974
|
Total Other Income
ÂĄ163m
|
CAGR 3-Years
19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
||
Pharma Foods International Co Ltd
TSE:2929
|
Total Other Income
ÂĄ209m
|
CAGR 3-Years
46%
|
CAGR 5-Years
29%
|
CAGR 10-Years
36%
|
||
S
|
StemRIM Inc
TSE:4599
|
Total Other Income
-ÂĄ1.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Cuorips Inc
TSE:4894
|
Total Other Income
-ÂĄ40.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
PeptiDream Inc
Glance View
PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. The company is headquartered in Kawasaki-Shi, Kanagawa-Ken and currently employs 141 full-time employees. The company went IPO on 2013-06-11. The firm operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The firm is involved in the business centered on drug development based on special peptides. The firm's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
See Also
What is PeptiDream Inc's Total Other Income?
Total Other Income
-1k
JPY
Based on the financial report for Sep 30, 2024, PeptiDream Inc's Total Other Income amounts to -1k JPY.
What is PeptiDream Inc's Total Other Income growth rate?
Total Other Income CAGR 1Y
50%
Over the last year, the Total Other Income growth was 50%.